References
- Mazer-Amirshahi M, Fox ER, Zocchi MS, et al. Longitudinal trends in U.S. shortages of sterile solutions, 2001–17. Am J Health Syst Pharm. 2018;75(23):1903–1908.
- Gottlieb S, Woodcock J. FDA is advancing new efforts to address drug shortages. 2018; [cited 2020 Oct 28]. Available from: https://www.fda.gov/news-events/fda-voices-perspectives-fda-leadership-and-experts/fda-advancing-new-efforts-address-drug-shortages.
- Self WH, Semler MW, Wanderer JP, et al. Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018;378(9):819–828.
- Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829–839.
- Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42(7):1585–1591.
- Cunningham FG, Leveno KJ, Bloom SL, et al. Renal and urinary tract disorders. In: Williams obstetrics. 25th ed. New York: McGraw-Hill. 2018.
- Jim B, Garovic VD. Acute kidney injury in pregnancy. Semin Nephrol. 2017;37(4):378–385.
- Morgan JL, Nelson DB, Roberts SW, et al. Association of baseline proteinuria an adverse outcomes in pregnant women with treated chronic hypertension. Obstet Gynecol. 2016;128(2):270–276.
- Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J. 1984;108(1):188–193.